Why BodyMedia will be the first of many acquisitions

Jun 28, 2011 Posted Under: Health Words  

While 2011 has brought with it a number of mobile health investment disclosures, there have been few mergers and acquisitions. GlowCaps-maker Vitality is one of the few exceptions. MobiHealthNews recently caught up with Zeo co-founder and CTO Ben Rubin to discuss the state of M&A in the consumer health space, and which company he believes to be the next likely acquisition target.

Rubin was quick with his answer: BodyMedia.

Zeo, the company Rubin co-founded, is one of the many device-centric consumer health companies. Zeo helps users track their sleep health and learn how to get a better nights rest.

Find more info…

Top stories in health and medicine this morning, June 30, 2011

Jun 28, 2011 Posted Under: Health Guide  

1. ICDs, Pacemakers Okay for Oldest Patients. Age should not be a barrier to treatment with permanent pacemakers or implantable cardioverter-defibrillators (ICDs).

2. Young Ca Survivors Face Lifelong Risk of More Cancers. One in 10 childhood cancer survivors faces a lifelong risk of developing at least one subsequent neoplasm, particularly if they were treated with radiation.

3. Seizure Drug Trial Called a Form of Marketing. A postmarketing study of the epilepsy drug gabapentin (Neurontin) sponsored by its manufacturer was intended mainly to turn its hundreds of clinician-investigators into enthusiasts for the product.

Hexane may be lurking in the soy protein found in popular food bars

Jun 27, 2011 Posted Under: Health Guide  

Protein bars, breakfast bars, really anything in bar form just makes sense in our dine while dashing society. The question is, what is it you’re really eating? Most of these bars claim to offer healthy, wholesome energy, but what you may not have realized is that the process to create “soy protein isolate,” which is often a primary ingredient in protein bars, utilizes a toxic solvent called Hexane.Hexane is an industrial waste by-product of gasoline that, according to the EPA, can cause polyneuropathy in humans. Hexane is primarily used as a solvent to extract edible oils from seed and vegetable crops, such as soybeans, as well as a solvent for glues, varnishes and inks. Find more info…

FDA unveils nine new graphic cigarette labels required in 2012

Jun 27, 2011 Posted Under: Health Quotes  

Washington – The FDA has unveiled nine new graphic warning labels that must appear on all cigarette packaging and advertising in the US beginning in the fall of 2012, in the most dramatic change to cigarette packs since the Surgeon General’s warning was added in 1965. Will graphic ads showing diseased ridden lungs, tracheotomy holes, babies in incubators, corpse’s with visible heart surgery incisions, and people dying from smoking related illnesses discourage smokers from lighting up? Find more info…

Vitamin B9 Supplementation May Reduce Rate Of Colon Cancer In Children

Jun 27, 2011 Posted Under: Health Quotes  

Besides ensuring the proper development of a babys nervous system, folic acid can reduce the risk of a number of birth defects. Now, researchers are saying that its protective effects may even extend to a childs later risk of colon cancer.

A study published in the medical journal Gut found that laboratory rodents fed folic acid supplements had offspring who were 64 percent less likely then their counterparts to develop colon cancer in adulthood.

Folic acid, also known as vitamin B9, is a vital nutrient that numerous health authorities recommend pregnant women take in the form of daily dietary supplements.

Find more info…

Results Released for Two Drug Studies Designed to Slow Progression of Type 1 Diabetes

Jun 27, 2011 Posted Under: Health Quotes  

The results of two diabetes drug studies, including one that shows promise for stopping the immune system’s attack on insulin-producing cells in people newly diagnosed with type I diabetes, were presented at the American Diabetes Associations Scientific Sessions in San Diego. They were simultaneously published online June 28 in the British medical journal The Lancet. The studies were conducted by the National Institutes of Health’s international network of researchers, Type 1 Diabetes TrialNet Study Group, which is led by the Miller School’s Jay Skyler, M.D.

Both TrialNet studies aimed to preserve secretion of insulin, the hormone that controls blood glucose levels one with the drug abatacept, and the other with a vaccine called glutamic acid decarboxylase (GAD). When

Find more info…

Page 30 of 44« First...1020...2829303132...40...Last »